Arrangement expands Cryoport's service agreement with the lab
Cryoport, Inc. (Lake Forest, CA), which combines a reusable, nitrogen-based deep-frozen shipping container with a cloud-based logistics management system called Cryoportal, has announced an expansion of its service agreement with Clinical Research Laboratory (CRL; Lenaxa, KS). CRL is one of the largest single-site testing labs in the US, handling millions of samples for clinical trials, molecular diagnostics, toxicology and other processes, for researchers in the US and abroad. “CRL is pleased to expand our portfolio of global logistics services by partnering with Cryoport to offer this quality based, cost effective technology solution,” said John Byerley, CRL’s VP of clinical trials operations, in a statement.
Cryoport has developed a novel container and shipping service for cryogenic sample movement. A cylindrical container holds liquid nitrogen (which avoids emissions of the carbon dioxide—and resulting hazardous-materials restrictions in air shipping—as compared to dry-ice-based refrigerants), with the container delivered ready for use, and labeled for pickup. At the receiving end, the used container can be readily returned to Cryoport for recharging. Cryoport has an agreement with FedEx for pickup, delivery and return; lab managers thus avoid the complexities of managing a delivery service. The Cryoportal, linked to FedEx’s tracking system, allows for ready access to shipment status.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.